Newstral
Article
timesofmalta.com on 2021-02-11 12:47
COVID vaccine maker AstraZeneca doubles profit
Related news
- COVID vaccine maker AstraZeneca logs loss as costs jumptimesofmalta.com
- Suspected North Korean hackers targeted COVID-19 vaccine maker AstraZenecaNew York Post
- AstraZeneca: won’t profit from COVID-19 vaccine in pandemicSeattle Times
- AstraZeneca says COVID vaccine sales top $1.0bntimesofmalta.com
- AstraZeneca doubles coronavirus vaccine production capacityNew York Post
- AstraZeneca COVID vaccine sales hit $275m in first quartertimesofmalta.com
- COVID-19 vaccine rollout unchanged despite EU blocking AstraZeneca shipmentSydney Morning Herald
- HAstraZeneca COVID-19 Vaccine Can Be 90% Effective, Results Showhamodia.com
- AstraZeneca says vaccine will be effective against COVID-19 variantstaradvertiser.com
- AstraZeneca says its vaccine will work against COVID-19 variantSydney Morning Herald
- AstraZeneca-Oxford vaccine prevents 70% of covid cases, study showsSydney Morning Herald
- AstraZeneca agrees to make COVID-19 vaccine for Europedailyherald.com
- AstraZeneca/Oxford say COVID vaccine shows 70% efficacytimesofmalta.com
- EU approves AstraZeneca vaccineDeutsche Welle Englisch
- Suspected North Korean hackers targeted COVID vaccine maker AstraZeneca – sourcesnewsday.co.zw
- AstraZeneca to book modest profit from coronavirus vaccineSeattle Times
- AstraZeneca moves to start making a profit from its vaccineSydney Morning Herald
- COVID-vaccine maker BioNTech reports $1.37B profit in Q1dailyherald.com
- HCOVID-Vaccine Maker BioNTech Reports $1.37B Profit in Q1hamodia.com